Name | Number of supported studies | Average coverage | |
---|---|---|---|
glutamatergic neuron | 8 studies | 32% ± 19% | |
epithelial cell | 5 studies | 29% ± 13% | |
neuron | 4 studies | 28% ± 11% | |
endothelial cell | 4 studies | 21% ± 3% | |
GABAergic neuron | 4 studies | 33% ± 9% | |
pancreatic A cell | 3 studies | 32% ± 12% | |
type B pancreatic cell | 3 studies | 38% ± 20% | |
enteroendocrine cell | 3 studies | 26% ± 9% | |
goblet cell | 3 studies | 17% ± 2% | |
oligodendrocyte | 3 studies | 19% ± 2% | |
astrocyte | 3 studies | 20% ± 3% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 9582.90 | 2642 / 2642 | 100% | 106.91 | 705 / 705 |
stomach | 100% | 2828.87 | 359 / 359 | 100% | 54.66 | 286 / 286 |
esophagus | 100% | 3413.37 | 1444 / 1445 | 100% | 57.51 | 183 / 183 |
bladder | 100% | 2810.05 | 21 / 21 | 100% | 64.26 | 503 / 504 |
intestine | 100% | 3219.46 | 966 / 966 | 99% | 59.65 | 524 / 527 |
breast | 100% | 2381.61 | 458 / 459 | 100% | 60.03 | 1114 / 1118 |
lung | 99% | 3391.43 | 575 / 578 | 100% | 64.01 | 1154 / 1155 |
prostate | 100% | 2595.60 | 244 / 245 | 100% | 70.03 | 501 / 502 |
skin | 100% | 3009.85 | 1802 / 1809 | 100% | 68.52 | 470 / 472 |
kidney | 100% | 2789.28 | 89 / 89 | 99% | 57.49 | 893 / 901 |
uterus | 99% | 1905.43 | 169 / 170 | 99% | 52.83 | 456 / 459 |
adrenal gland | 100% | 5124.65 | 258 / 258 | 99% | 68.64 | 227 / 230 |
thymus | 100% | 2812.78 | 651 / 653 | 99% | 47.10 | 597 / 605 |
pancreas | 98% | 2056.00 | 321 / 328 | 99% | 56.42 | 176 / 178 |
ovary | 97% | 1547.34 | 175 / 180 | 99% | 40.50 | 427 / 430 |
liver | 95% | 2072.06 | 215 / 226 | 95% | 36.64 | 385 / 406 |
lymph node | 0% | 0 | 0 / 0 | 100% | 45.66 | 29 / 29 |
muscle | 100% | 5752.50 | 803 / 803 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 63.15 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 51.87 | 1 / 1 |
adipose | 100% | 2799.15 | 1203 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 3408.73 | 1331 / 1335 | 0% | 0 | 0 / 0 |
spleen | 99% | 1791.95 | 238 / 241 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 96% | 39.01 | 77 / 80 |
heart | 96% | 2997.11 | 824 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 72% | 1728.78 | 669 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0000209 | Biological process | protein polyubiquitination |
GO_0035556 | Biological process | intracellular signal transduction |
GO_0005829 | Cellular component | cytosol |
Gene name | WSB2 |
Protein name | WD repeat and SOCS box-containing protein 2 (WSB-2) (CS box-containing WD protein) WD repeat and SOCS box containing 2 |
Synonyms | |
Description | FUNCTION: May be a substrate-recognition component of a SCF-like ECS (Elongin-Cullin-SOCS-box protein) E3 ubiquitin ligase complex which mediates the ubiquitination and subsequent proteasomal degradation of target proteins. . |
Accessions | ENST00000544233.5 [Q9NYS7-3] ENST00000441406.6 [Q9NYS7-2] F5H280 ENST00000543218.5 ENST00000315436.8 [Q9NYS7-1] ENST00000543186.1 F5H2L7 Q9NYS7 ENST00000537945.1 F5GXB6 ENST00000535496.5 F5H024 |